Skip to content

LBRX LBRX Shares (Diluted)

Shares (Diluted) at other companies

Alkermes logo
AlkermesALKS
166.2M-1.5%
MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
45.3M+5,845%
Alto Neuroscience logo
Alto NeuroscienceANRO
32.9M+21.6%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
60.2M+11.3%
Opko Health logo
Opko HealthOPK
758.9M+13.0%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
172.7M+3.0%

Other financials

Income statement

See full
Net income-$19.1M-259%
EPS (diluted)-$0.67+95.5%

Balance sheet

See full
Cash & equivalents$320.7M
Total debt$3.5M
Total equity$378.7M+481%
Total assets$393.5M

Cash flow

See full
Operating cash flow-$23.3M-187%
CapEx$32.0K+52.4%
Free cash flow-$23.3M-186%

Valuation

See full
Market cap$874.06M+159%
Enterprise value$556.86M

Returns & leverage

See full
Return on equity-27.9%
Debt / equity
Current ratio35.7×

Where this comes from

Reported directly by LBRX in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment.

The official record: LBRX’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about LBRX's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LBRX's shares (diluted)?
LBRX (LBRX) reported shares (diluted) of 28.2M in Q1 2026.
How has LBRX's shares (diluted) changed year-over-year?
LBRX's shares (diluted) increased by 7771.7% year-over-year, from 358.8K to 28.2M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.